Covidien, a leading global provider of healthcare products, and Nuvo Research Inc, a Canadian drug development company, announced that the US Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid Topical Solution (diclofenac sodium topical solution) 1.5% w/w.
The details can be read here.
No comments:
Post a Comment